Derivative Financial Instruments (Tables)

6 Months Ended

Jun. 28, 2020

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Schedule of Fair Values of the Company's Derivative Instruments and the Line Items on the Unaudited Condensed Consolidated Balance Sheets

The fair values of the Company’s derivative instruments and the line items on the unaudited condensed consolidated balance sheets to which they were recorded as of June 28, 2020, and December 31, 2019, are summarized as follows:

	Balance Sheet					Balance Sheet
	Location	June 28, 2020		December 31, 2019		Location	June 28, 2020		December 31, 2019
		(In thousands)					(In thousands)
Derivatives not designated as hedging instruments	Prepaid expenses and other current assets	$	261	$	109	Other accrued liabilities	$	1,336	$	493
Derivatives designated as hedging instruments	Prepaid expenses and other current assets		12		43	Other accrued liabilities		—		32
Total		$	273	$	152		$	1,336	$	525

Schedule of Company's Derivative Instruments on Accumulated Other Comprehensive Income and the Unaudited Condensed Consolidated Statement of Operations

The effect of the Company’s derivative instruments on AOCI and the unaudited condensed consolidated statements of operations for the three and six months ended June 28, 2020 and June 30, 2019 are summarized as follows:

	Three Months Ended						Six Months Ended
	June 28, 2020			June 30, 2019			June 28, 2020			June 30, 2019
Derivatives designated as hedging instruments:
Cash flow hedges
Foreign currency forward contracts:
Gains (losses) recognized in accumulated other comprehensive income- Effective Portion	$	(63	)	$	534		$	922		$	863
Gains (losses) reclassified from accumulated other comprehensive income into Income -Effective Portion (1):
Net revenue	$	343		$	672		$	1,019		$	1,086
Cost of revenue	$	1		$	(6	)	$	(1	)	$	(8	)
Research and development	$	7		$	(20	)	$	5		$	(46	)
Sales and marketing	$	5		$	(98	)	$	(72	)	$	(167	)
General and administrative	$	(1	)	$	(12	)	$	(14	)	$	(23	)
Derivatives not designated as hedging instruments:
Gains (losses) recognized in Other income (expense), net	$	(1,128	)	$	304		$	650		$	906

^{(1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.}